Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Colorectal Carcinoma
|
1962 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.900 | 0.964 | 28 | 2007 | 2019 | ||||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
368 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.800 | 1.000 | 8 | 2007 | 2019 | ||||||
Malignant tumor of colon
|
688 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.750 | 1.000 | 12 | 2007 | 2019 | ||||||
Adenocarcinoma of large intestine
|
432 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.700 | 1.000 | 8 | 2007 | 2019 | ||||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
374 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.700 | 1.000 | 8 | 2007 | 2019 | ||||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
370 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.700 | 1.000 | 8 | 2007 | 2019 | ||||||
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
373 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.700 | 1.000 | 8 | 2007 | 2019 | ||||||
Colorectal Neoplasms
|
609 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.700 | 1.000 | 8 | 2007 | 2019 | ||||||
Malignant neoplasm of large intestine
|
375 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.700 | 1.000 | 8 | 2007 | 2019 | ||||||
Finding of Mean Corpuscular Hemoglobin
|
1206 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||
Nasopharyngeal carcinoma
|
320 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.700 | 1.000 | 1 | 2010 | 2010 | ||||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.070 | 1.000 | 7 | 2009 | 2017 | ||||||
Colon Carcinoma
|
275 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.050 | 1.000 | 5 | 2008 | 2016 | ||||||
Rectal Carcinoma
|
112 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.020 | 1.000 | 2 | 2012 | 2016 | ||||||
Alcohol or Other Drugs use
|
21 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Colonic Neoplasms
|
45 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||||
Drug usage
|
21 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
Esophageal carcinoma
|
272 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Esophageal Neoplasms
|
270 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Familial (FPAH)
|
276 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
Malignant neoplasm of esophagus
|
214 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Malignant Neoplasms
|
1641 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.010 | 1 | 2011 | 2011 | |||||||
Neoplasms
|
1644 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Primary malignant neoplasm
|
1374 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.010 | 1 | 2011 | 2011 | |||||||
Tumor Cell Invasion
|
169 | 0.708 | 0.160 | 18 | 48927093 | intron variant | T/A;C | snv | 0.010 | 1.000 | 1 | 2016 | 2016 |